KI & ML · 23. Mai
Big Pharma's AI Math: When Boehringer Ingelheim Plants Flags in London's Knowledge Quarter
The German pharmaceutical giant's new London AI center reveals how traditional drug companies are quietly building the infrastructure for computational drug discovery
- Pharmaceutical companies are establishing AI labs in tech talent clusters rather than traditional pharma hubs to compete for computational biology expertise
- Corporate AI accelerators serve as talent magnets and recruiting pipelines, offering unique career paths combining machine learning with drug discovery applications